Arrhythmia Research Technology, Inc.  

(Public, NYSEMKT:HRT)   Watch this stock  
Find more results for HRT
+0.28 (6.97%)
Feb 22 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 4.10 - 4.36
52 week 3.47 - 4.83
Open 4.36
Vol / Avg. 7,179.00/3,518.00
Mkt cap 12.25M
P/E     -
Div/yield     -
EPS -0.28
Shares 2.82M
Beta 0.22
Inst. own 13%
Mar 8, 2017
Q4 2016 Arrhythmia Research Technology Inc Earnings Release (Estimated) Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -1.45% -3.68%
Operating margin 0.02% -2.42%
EBITD margin - 4.39%
Return on average assets -1.93% -5.56%
Return on average equity -4.16% -11.21%
Employees 98 -
CDP Score - -


25 Sawyer Passway
United States - Map
+1-978-3455000 (Phone)
+1-978-3420168 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Arrhythmia Research Technology, Inc. is a contract manufacturing organization. The Company, through its subsidiary, Micron Products, Inc. (Micron), produces medical device technologies requiring precision machining and injection molding. Micron provides design, engineering, quality and regulatory expertise across the Company's product lines, including machining, plastic injection molding and sensors. It manufactures replacement knee systems, including femorals, tibial trays, inserts and instrumentation from investment castings (F-75, stainless steel), ultra-high-molecular-weight polyethylene (UHMWPE), ultrasonic cleaning and passivation. Its plastic injection molding services include clean room molding and tight tolerance specifications of engineered materials. It provides its customers with services, including the design, manufacture and rehabilitation of injection molding tools. Micron is a manufacturer and distributor of silver-plated and non-silver plated conductive resin sensors.

Officers and directors

E. P. Marinos Independent Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Salvatore Emma Jr. President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Derek T. Welch Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Robert A. Mello Director
Age: 61
Bio & Compensation  - Reuters
.. S. .. Independent Director
Age: 51
Bio & Compensation  - Reuters
Marco F. Benedetti Independent Director
Age: 56
Bio & Compensation  - Reuters
Jason R. Chambers Independent Director
Age: 37
Bio & Compensation  - Reuters
Paul F. Walter M.D. Independent Director
Age: 78
Bio & Compensation  - Reuters